Deleted Tweets From Scott Gottlieb, R-D.C.

RT @Surgeon_General: Watch: @NBCNightlyNews with @LesterHoltNBC tonight for my conversation w @DrJohnTorres about my plans to address op… https://t.co/0apLKtyo6c

RT @sarahdespres: We look forward to continued work with #FDA & other stakeholders on using data to help improve antibiotic use in fo… https://t.co/qc3EALPaH3

#FDA has, and will continue to act when it learns of deceptive sale or advertising of products that claim to effectively treat opioid use disorder, but which have not been proven safe and effective for these purposes. https://t.co/mxX8KazBll QT @NYTHealth: Companies tout dietary supplements to aid in opioid withdrawal, but lack proof they actually work https://t.co/krNS6Xhbfw)

RT @califf001: Bravo. Amazing how most people respond with high quality well intentioned approaches when there is a crisis, but t… QT @SGottliebFDA: #FDA has, and will continue to act when it learns of deceptive sale or advertising of products that claim to effect… https://t.co/FAYpm9aCWa)

RT @FDAOncology: Congratulations to @FDAOncology Director Richard Pazdur @realrickpazdur for being named the 2018 recipient of the A… https://t.co/KjGwnLruTW

Join us! FDA to hold public workshop on patient-focused drug development Dec. 18 in person or online #PFDD https://t.co/pjIqEbJ0iM

Smoking is responsible for 480,000 deaths in the U.S. each year. #FDA’s new campaign, #EveryTryCounts, motivates cigarette smokers to quit through messages of support that underscore the health benefits of quitting: https://t.co/ffMQq1Sfyu

#FDA continues to pursue new reforms to the generic approval process to foster competition, access, lower drug prices: https://t.co/HR4FFqhpbt

RT @SGottliebFDA: My remarks today on new steps #FDA is taking on opioid addiction; how we can use packaging and electronic reporting… https://t.co/1seF82JtuR

#FDA is modernizing it’s approach to medical device clearance process; to let new innovations be evaluated against modern, rigorous, consensus standards in cases where existing predicates — used for comparative purposes — are out-of-date https://t.co/04PH

RT @SGottliebFDA: #FDA’s social science research on prescription drug promotion, and studying consumer and health care providers’ abi… https://t.co/ZyqOEVRzWX

RT @califf001: The public will benefit greatly from revamping OTC med regulation--better information and incorporation of evolving… QT @statnews: Lawmakers are moving to overhaul the way over-the-counter drugs are treated — and to ensure the FDA can move more n… https://t.co/aRZnuPugQK)

RT @US_FDA: Looking for resources about our new #EveryTryCounts campaign? Visit the @FDATobacco page below. https://t.co/nPwuNU5CTr QT @FDATobacco: @US_FDA @NCICancerCtrl @PennMedicine Find out more about #EveryTryCounts: https://t.co/N8AdH4ENzT https://t.co/ALWYKlftdj)

FDA issues first report on patient reported outcomes in medical device premarket submissions and postmarket studies: https://t.co/om1XJNrSfT

RT @annaedney: Gluten free isn't just for food anymore FDA issues guideline for drugmakers that want to highlight that their prod… https://t.co/PkNFFbztKY

#FDA provides drug makers with advice on how to label for gluten in certain drug products: https://t.co/V00GjjjWKH

#FDA warns companies for promoting alternatives to street drugs: https://t.co/kjTX3Na9U0

RT @FDAOMH: This new campaign from @FDATobacco uses positive messages in stores to motivate adult smokers to try quitting and p… https://t.co/EmNKo1H4nH

RT @HouseCommerce: Chairman @repgregwalden, #SubHealth Chair @michaelcburgess on @POTUS's signing of NDAA Conference Report + bill to… https://t.co/b3PvS8eHz4

RT @FDATobacco: We’re excited to be in D.C. this morning for the launch of @US_FDA’s new adult smoking cessation education campaign… https://t.co/nP0KbFEIcU

RT @Surgeon_General: Watch: @NBCNightlyNews with @LesterHoltNBC tonight for my conversation w @DrJohnTorres about my plans to address op… https://t.co/0apLKtyo6c

RT @sarahdespres: We look forward to continued work with #FDA & other stakeholders on using data to help improve antibiotic use in fo… https://t.co/qc3EALPaH3

#FDA has, and will continue to act when it learns of deceptive sale or advertising of products that claim to effectively treat opioid use disorder, but which have not been proven safe and effective for these purposes. https://t.co/mxX8KazBll QT @NYTHealth: Companies tout dietary supplements to aid in opioid withdrawal, but lack proof they actually work https://t.co/krNS6Xhbfw)

RT @califf001: Bravo. Amazing how most people respond with high quality well intentioned approaches when there is a crisis, but t… QT @SGottliebFDA: #FDA has, and will continue to act when it learns of deceptive sale or advertising of products that claim to effect… https://t.co/FAYpm9aCWa)

RT @FDAOncology: Congratulations to @FDAOncology Director Richard Pazdur @realrickpazdur for being named the 2018 recipient of the A… https://t.co/KjGwnLruTW

Join us! FDA to hold public workshop on patient-focused drug development Dec. 18 in person or online #PFDD https://t.co/pjIqEbJ0iM

Smoking is responsible for 480,000 deaths in the U.S. each year. #FDA’s new campaign, #EveryTryCounts, motivates cigarette smokers to quit through messages of support that underscore the health benefits of quitting: https://t.co/ffMQq1Sfyu

#FDA continues to pursue new reforms to the generic approval process to foster competition, access, lower drug prices: https://t.co/HR4FFqhpbt

RT @SGottliebFDA: My remarks today on new steps #FDA is taking on opioid addiction; how we can use packaging and electronic reporting… https://t.co/1seF82JtuR

#FDA is modernizing it’s approach to medical device clearance process; to let new innovations be evaluated against modern, rigorous, consensus standards in cases where existing predicates — used for comparative purposes — are out-of-date https://t.co/04PH

RT @SGottliebFDA: #FDA’s social science research on prescription drug promotion, and studying consumer and health care providers’ abi… https://t.co/ZyqOEVRzWX

RT @califf001: The public will benefit greatly from revamping OTC med regulation--better information and incorporation of evolving… QT @statnews: Lawmakers are moving to overhaul the way over-the-counter drugs are treated — and to ensure the FDA can move more n… https://t.co/aRZnuPugQK)

RT @US_FDA: Looking for resources about our new #EveryTryCounts campaign? Visit the @FDATobacco page below. https://t.co/nPwuNU5CTr QT @FDATobacco: @US_FDA @NCICancerCtrl @PennMedicine Find out more about #EveryTryCounts: https://t.co/N8AdH4ENzT https://t.co/ALWYKlftdj)

FDA issues first report on patient reported outcomes in medical device premarket submissions and postmarket studies: https://t.co/om1XJNrSfT

RT @annaedney: Gluten free isn't just for food anymore FDA issues guideline for drugmakers that want to highlight that their prod… https://t.co/PkNFFbztKY

#FDA provides drug makers with advice on how to label for gluten in certain drug products: https://t.co/V00GjjjWKH

#FDA warns companies for promoting alternatives to street drugs: https://t.co/kjTX3Na9U0

RT @FDAOMH: This new campaign from @FDATobacco uses positive messages in stores to motivate adult smokers to try quitting and p… https://t.co/EmNKo1H4nH

RT @HouseCommerce: Chairman @repgregwalden, #SubHealth Chair @michaelcburgess on @POTUS's signing of NDAA Conference Report + bill to… https://t.co/b3PvS8eHz4

RT @FDATobacco: We’re excited to be in D.C. this morning for the launch of @US_FDA’s new adult smoking cessation education campaign… https://t.co/nP0KbFEIcU